Oncolytics Biotech (Canada)
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Oncolytics Biotech (Canada), Canada, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
245
Total Open
Publications
120
Total
Citations
7.1K
Open Access
Percentage
49%
Total
Publications
245
Total Open
Publications
120
Total
Citations
7.1K
Breakdown
Publisher Open
21%
Both
22%
Other Platform Open
5%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 42%
43
Hybrid 32%
33
No Guarantees 26%
26
Other Platform Open
Domain 92%
60
Other Internet 14%
9
Institution 9%
6
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 60 |
DOI | Other Internet | 7 |
Unknown Repository | Other Internet | 2 |
Europe PMC | Domain | 2 |
Université Laval - Corpus Université Laval | Institution | 1 |
University of Melbourne - Minerva Access | Institution | 1 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
The University of Arizona - UA Campus Repository | Institution | 1 |
Jackson Laboratory - The Mouseion at the JAXlibrary | Institution | 1 |
DANS - Data Archiving and Networked Services | Institution | 1 |